Boxer Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
TA
Boxer Capital Management's RIGL Position: Q4 2018 in Review
Boxer Capital Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2018, closing a stake of 232,190 shares — an estimated $7.45M sold.
Boxer Capital Management first reported a position in RIGL in Q2 2016 and held it in 6 quarters. The position peaked at $18.2M in Q1 2018. 132 funds tracked by Wall St. Rank hold RIGL as of Q4 2018.
- Boxer Capital Management reported no remaining Rigel Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
- Boxer Capital Management sold 232,190 Rigel Pharmaceuticals shares in Q4 2018, an estimated $7.45M.
- Boxer Capital Management first reported a position in Rigel Pharmaceuticals in Q2 2016 and held it in 6 quarters.
- Boxer Capital Management's Rigel Pharmaceuticals position peaked at $18.2M in Q1 2018.
- 132 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2018.
Based on Boxer Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.